|
Institute of Medicine Committee on Methodological Challenges in HIV Prevention Trials Public Meeting Radisson Edwardian Kenilworth Hotel Bloomsbury Suite 97 Great Russell Street London WC1B 3LB
April 19, 2007
AGENDA
8:30 – 8:40 a.m. Welcome and Overview Steve Lagakos, Ph.D. (Chair), Professor of Biostatistics, Department of Biostatistics, Harvard School of Public Health
Issues in Trial Design and Implementation
8:40 – 9:05 a.m. (20 minutes; 5 Q&A) Site preparedness and implementation of late-stage HIV prevention efficacy trials in resource-limited settings Gita Ramjee, Ph.D., Director, South African Medical Research Council, HIV Prevention Unit
9:05 – 9:30 a.m. (20 minutes; 5 Q&A) Context, challenges, and new ideas for HIV prevention trials Helen Rees, O.B.E. , Executive Director, Reproductive Health and HIV Research Unit, Department of Obstetrics and Gynecology, University of the Witwatersrand
9:30 – 9:55 a.m. (20 minutes; 5 Q&A) Accuracy of self-reported sexual behavior James J. Jaccard, Ph.D., Professor, Department of Psychology, Florida International University
9:55 – 10:10 a.m. BREAK
10:10 – 10:35 a.m. (20 minutes; 5 Q&A) Measurement of adherence, sexual behavior, and product acceptability in MDP PRO 2000 microbicide trial Robert Pool, Ph.D., Senior Lecturer in Social Anthropology, London School of Hygiene & Tropical Medicine
10:35 –11:00 a.m. (20 minutes; 5 Q&A) Issues in microbicide trial design, monitoring, and analysis Andrew Nunn, MSc., Associate Director, Medical Research Council (MRC), Clinical Trials Unit
11:00 –11:25 a.m. (20 minutes; 5 Q&A) Microbicide Product Development and Implications for Future Trials Robin Shattock, Ph.D., Reader in Cell Biology of Infection, Department of Cellular and Molecular Medicine, St. George’s Hospital Medical School
11:25 – 12:15 p.m Panel Discussion
12:15 – 1:00 p.m. LUNCH
HIV Prevention Trials (Non-PrEP or Microbicide)
1:00 – 1:25 p.m. (20 minutes; 5 Q&A) Male Circumcision to Prevent HIV Acquisition in Young Men in Kisumu, Kenya Kawango Agot, Ph.D., M.P.H. Coordinator and Co-Investigator, Universities of Nairobi, Illinois and Manitoba (UNIM) Project; Lumumba Health Center, University of Nairobi, Kenya
1:25 – 1:50 p.m. (20 minutes; 5 Q&A) Male Circumcision to Prevent HIV Acquisition and Transmission in Rakai, Uganda Maria J. Wawer, M.D.,M.P.H. Professor, Department of Population, Family, and Reproductive Health, Bloomberg School of Public Health Johns Hopkins University
1:50 – 2:15 p.m. (20 minutes; 5 Q&A) Lessons learned from STD treatment trials for HIV prevention Maria J. Wawer, M.D., M.P.H Professor, Department of Population, Family, and Reproductive Health Bloomberg School of Public Health Johns Hopkins University
2:15 – 2:40 p.m. (20 minutes; 5 Q&A) Phase III Randomized Placebo-Controlled Trial of HSV-2 Suppression to Prevent HIV Transmission among HIV-Discordant Couples Connie Celum, M.D., M.P.H, Professor of Medicine & Adjunct Professor of Epidemiology Division of Allergy and Infectious Diseases, University of Washington School of Medicine
2:40 – 3:00 p.m. Break
3:00 – 4:00 p.m. Panel Discussion
4:00 – 4:30 p.m. (20 minutes; 10 Q&A) The latex diaphragm to prevent HIV acquisition among women: A female-controlled, physical barrier of the cervix Nancy Padian, Ph.D., M.P.H., Executive Director of Research, Global Health Sciences, Professor, Departments of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco
4:30 – 5:00 p.m. (20 minutes; 10 Q&A) Key Summary Points and Discussion Kenneth H. Mayer, M.D., Professor of Medicine and Community Health, Director, Brown University AIDS Program, Brown University, Attending physician, Division of Infectious Diseases, The Miriam Hospital, Research Medical Director, Fenway Community Health
5:00 p.m. Adjourn
5:15 – 6:30 p.m. Reception
|